Here's something worth chewing on: prescription drug prices in the States are wildly inflated compared to what other nations pay. We're talking multiples, not percentages.

The root cause? There's a middleman layer that's raking in massive profits, and the system has zero incentive to fix it. Government officials could negotiate better terms, but they don't. Why? Because those intermediaries have their fingers deep in the pie, and disrupting that cash flow isn't on anyone's agenda.

This isn't just about healthcare—it's a textbook example of what happens when centralized systems prioritize profit extraction over actual value delivery. The markup doesn't benefit patients, doesn't fund research, just feeds an unnecessary layer that exists purely because the structure allows it.

Makes you wonder what other industries operate on similar playbooks. When transparency is absent and intermediaries control the flow, consumers always end up holding the bag.